Report overview
Fusion proteins?or?chimeric?(k?-?mir-ik)?proteins?(literally, made of parts from different sources) are proteins created through the joining of two or more?genes?that originally coded for separate proteins.?
This report aims to provide a comprehensive presentation of the global market for Fusion Protein Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fusion Protein Therapy. This report contains market size and forecasts of Fusion Protein Therapy in global, including the following market information:
Global Fusion Protein Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Fusion Protein Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Immunoglobulin (Ig) Fusion Protein Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fusion Protein Therapy include Roche, Abnova, Novus, Origene, Chimerigen, Peprotech, Prospec, Aboslute Antibody and Amgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fusion Protein Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fusion Protein Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Fusion Protein Therapy Market Segment Percentages, by Type, 2022 (%)
Immunoglobulin (Ig) Fusion Protein
Parathyroid Hormone (PTH) Fusion Protein
Cytokines Recombinant Fusion Protein
Others
Global Fusion Protein Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Fusion Protein Therapy Market Segment Percentages, by Application, 2022 (%)
Chimeric Protein Drugs
Biological Technology
Others
Global Fusion Protein Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Fusion Protein Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fusion Protein Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Fusion Protein Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abnova
Novus
Origene
Chimerigen
Peprotech
Prospec
Aboslute Antibody
Amgen
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fusion Protein Therapy, market overview.
Chapter 2: Global Fusion Protein Therapy market size in revenue.
Chapter 3: Detailed analysis of Fusion Protein Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fusion Protein Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
